A
Armata Pharmaceuticals Inc
F:TG1N
Armata Pharmaceuticals Inc
F:TG1N
Price:
8.25
EUR
11.49%
Market Closed
Market Cap:
€298.2m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Armata Pharmaceuticals Inc
F:TG1N
|
US |
|
H
|
Hanwha Galleria Corp
KRX:452260
|
KR |
|
Plano & Plano Desenvolvimento Imobiliario SA
BOVESPA:PLPL3
|
BR |
|
H
|
H & M Hennes & Mauritz AB
OTC:HMRZF
|
SE |
|
Jack Henry & Associates Inc
NASDAQ:JKHY
|
US |
|
Auckland International Airport Ltd
NZX:AIA
|
NZ |
|
H
|
Haina Intelligent Equipment International Holdings Ltd
HKEX:1645
|
CN |
|
I
|
INOX India Ltd
NSE:INOXINDIA
|
IN |
|
C&C Group PLC
LSE:CCR
|
IE |
|
S
|
Suzhou West Deane New Power Electric Co Ltd
SSE:603312
|
CN |
|
C
|
Choil Aluminum Co Ltd
KRX:018470
|
KR |
|
W
|
Ways Electron Co Ltd
SSE:605218
|
CN |
|
China Jinmao Holdings Group Ltd
HKEX:817
|
HK |
Balance Sheet
Balance Sheet Decomposition
Armata Pharmaceuticals Inc
Armata Pharmaceuticals Inc
Balance Sheet Decomposition is not available for
Armata Pharmaceuticals Inc
Armata Pharmaceuticals Inc
Balance Sheet
Armata Pharmaceuticals Inc
Armata Pharmaceuticals Inc
Currency: USD
| Dec-1999 | Dec-2000 | Dec-2001 | Dec-2002 | Dec-2003 | Dec-2004 | Dec-2005 | Dec-2006 | Dec-2007 | Dec-2008 | Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||||||||
| Cash & Cash Equivalents |
4
|
39
|
25
|
13
|
21
|
34
|
14
|
6
|
16
|
5
|
1
|
1
|
20
|
7
|
9
|
6
|
5
|
8
|
6
|
10
|
10
|
15
|
14
|
9
|
|
| Cash Equivalents |
4
|
39
|
25
|
13
|
21
|
34
|
14
|
6
|
16
|
5
|
1
|
1
|
20
|
7
|
9
|
6
|
5
|
8
|
6
|
10
|
10
|
15
|
14
|
9
|
|
| Short-Term Investments |
3
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
2
|
3
|
3
|
1
|
0
|
0
|
0
|
2
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
1
|
|
| Accounts Receivables |
2
|
3
|
3
|
1
|
0
|
0
|
0
|
2
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
1
|
0
|
0
|
1
|
1
|
1
|
0
|
0
|
0
|
1
|
0
|
0
|
1
|
1
|
0
|
0
|
1
|
1
|
5
|
12
|
2
|
1
|
|
| Total Current Assets |
9
|
42
|
29
|
14
|
22
|
35
|
15
|
8
|
19
|
6
|
2
|
2
|
21
|
7
|
10
|
6
|
5
|
8
|
7
|
11
|
15
|
27
|
19
|
11
|
|
| PP&E Net |
4
|
6
|
8
|
6
|
3
|
3
|
2
|
1
|
1
|
1
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
4
|
13
|
38
|
47
|
57
|
55
|
|
| PP&E Gross |
4
|
6
|
8
|
6
|
3
|
3
|
2
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
4
|
13
|
38
|
47
|
57
|
55
|
|
| Accumulated Depreciation |
7
|
8
|
11
|
11
|
13
|
14
|
15
|
15
|
16
|
16
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
2
|
8
|
9
|
10
|
11
|
12
|
13
|
|
| Intangible Assets |
0
|
2
|
2
|
1
|
1
|
32
|
32
|
8
|
8
|
0
|
0
|
13
|
13
|
13
|
13
|
11
|
5
|
3
|
10
|
10
|
10
|
10
|
10
|
10
|
|
| Goodwill |
0
|
36
|
30
|
31
|
31
|
0
|
0
|
0
|
0
|
0
|
10
|
7
|
8
|
8
|
8
|
0
|
0
|
0
|
3
|
3
|
3
|
3
|
3
|
3
|
|
| Other Long-Term Assets |
0
|
2
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
2
|
3
|
8
|
8
|
6
|
|
| Other Assets |
0
|
36
|
30
|
31
|
31
|
0
|
0
|
0
|
0
|
0
|
10
|
7
|
8
|
8
|
8
|
0
|
0
|
0
|
3
|
3
|
3
|
3
|
3
|
3
|
|
| Total Assets |
14
N/A
|
88
+543%
|
71
-19%
|
53
-26%
|
58
+9%
|
70
+21%
|
49
-30%
|
17
-64%
|
28
+63%
|
7
-75%
|
11
+61%
|
22
+92%
|
41
+87%
|
29
-31%
|
31
+10%
|
18
-42%
|
11
-39%
|
12
+7%
|
25
+114%
|
40
+55%
|
70
+77%
|
96
+37%
|
98
+3%
|
86
-12%
|
|
| Liabilities | |||||||||||||||||||||||||
| Accounts Payable |
3
|
4
|
5
|
2
|
1
|
1
|
2
|
2
|
2
|
2
|
0
|
2
|
2
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
4
|
5
|
2
|
|
| Accrued Liabilities |
1
|
1
|
1
|
2
|
3
|
1
|
2
|
2
|
2
|
1
|
0
|
0
|
0
|
0
|
0
|
2
|
1
|
2
|
3
|
3
|
3
|
21
|
11
|
7
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
1
|
1
|
1
|
1
|
1
|
1
|
0
|
1
|
0
|
0
|
0
|
4
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
39
|
|
| Other Current Liabilities |
0
|
7
|
5
|
6
|
1
|
0
|
0
|
0
|
0
|
1
|
2
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
1
|
2
|
0
|
0
|
1
|
1
|
|
| Total Current Liabilities |
5
|
12
|
12
|
11
|
7
|
4
|
5
|
5
|
5
|
4
|
2
|
6
|
2
|
2
|
2
|
4
|
2
|
3
|
5
|
7
|
5
|
25
|
16
|
48
|
|
| Long-Term Debt |
2
|
2
|
16
|
20
|
11
|
10
|
8
|
1
|
0
|
0
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
82
|
55
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
3
|
3
|
3
|
2
|
1
|
1
|
3
|
3
|
3
|
3
|
3
|
3
|
|
| Minority Interest |
0
|
0
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
10
|
6
|
2
|
6
|
6
|
5
|
6
|
8
|
7
|
0
|
0
|
58
|
18
|
2
|
2
|
0
|
0
|
3
|
11
|
36
|
32
|
29
|
28
|
|
| Total Liabilities |
7
N/A
|
25
+265%
|
34
+37%
|
35
+3%
|
24
-30%
|
20
-16%
|
18
-10%
|
12
-34%
|
12
+1%
|
11
-11%
|
4
-60%
|
9
+111%
|
63
+591%
|
23
-63%
|
7
-70%
|
8
+22%
|
3
-60%
|
3
N/A
|
11
+218%
|
21
+90%
|
44
+115%
|
60
+35%
|
130
+118%
|
134
+3%
|
|
| Equity | |||||||||||||||||||||||||
| Common Stock |
110
|
0
|
12
|
13
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
1
|
3
|
2
|
12
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
103
|
151
|
178
|
202
|
217
|
231
|
250
|
284
|
300
|
321
|
319
|
321
|
385
|
362
|
363
|
381
|
394
|
406
|
158
|
180
|
203
|
240
|
309
|
328
|
|
| Additional Paid In Capital |
0
|
214
|
203
|
207
|
249
|
280
|
281
|
289
|
316
|
317
|
326
|
333
|
361
|
365
|
375
|
391
|
402
|
414
|
172
|
198
|
228
|
275
|
276
|
279
|
|
| Unrealized Security Profit/Loss |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
7
N/A
|
63
+810%
|
37
-41%
|
18
-52%
|
33
+87%
|
50
+49%
|
31
-39%
|
5
-82%
|
16
+202%
|
4
N/A
|
7
N/A
|
13
+81%
|
22
N/A
|
5
N/A
|
25
+353%
|
10
-60%
|
8
-20%
|
8
+10%
|
15
+72%
|
19
+29%
|
25
+35%
|
36
+42%
|
32
N/A
|
48
-50%
|
|
| Total Liabilities & Equity |
14
N/A
|
88
+543%
|
71
-19%
|
53
-26%
|
58
+9%
|
70
+21%
|
49
-30%
|
17
-64%
|
28
+63%
|
7
-75%
|
11
+61%
|
22
+92%
|
41
+87%
|
29
-31%
|
31
+10%
|
18
-42%
|
11
-39%
|
12
+7%
|
25
+114%
|
40
+55%
|
70
+77%
|
96
+37%
|
98
+3%
|
86
-12%
|
|
| Shares Outstanding | |||||||||||||||||||||||||
| Common Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
2
|
10
|
19
|
27
|
36
|
36
|
36
|
|
| Preferred Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
9
|
9
|
8
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Switch to:
Switch to:
See Also
Discover More
